Answers are grounded in this paper and cite their sources.
Interleukin 6 (IL-6)/signal transducer and activator of transcription 3 (STAT3) signaling is considered to have important oncogenic functions in prostate cancer (PCa). However, a recent study highlighted the central role of IL-6/STAT3 signaling in regulation of the ARF-MDM2-p53 senescence axis. This reversal of the postulated oncogenic properties of IL-6/STAT3 signaling in PCa has important therapeutic implications.
No takes yet. Share an insight, caveat, or question.
Čulig et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: